WalkAide FES device Improves Gait Function and Quality of Life for People with Multiple Sclerosis on Ampyra 


Lori Mayer  MSN MSCN CCRP, Tina  Warring PT,  Stephanie Agrella ANP-BC MSCN, Edward J. Fox MD PhD 

Presented on October 12, 2012, during the 28th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, the study results concluded that the WalkAide® System significantly improves gait speed, endurance, gait quality, QOL and decreases the impact of MS on gait. Improvements, above those seen with Ampyra, suggest the WalkAide® can augment pharmacological intervention and significantly improve gait, function and QOL for people with MS. This was the first study to examine the effects of combining the WalkAide System and pharmaceutical intervention. To review the study abstract click here and to review the poster click here.

ECTRIMS hosts the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis (MS).